Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Abiomed, Inc.    ABMD


SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

ABIOMED INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

10/29/2020 | 06:24am EST

Item 2.02 Results of Operations and Financial Condition.

On October 29, 2020, ABIOMED, Inc. (the "Company," "we" or "us") issued a press release reporting our financial results for our second quarter ended September 30, 2020. A copy of the press release is set forth as Exhibit 99.1 and is incorporated herein by reference. The information contained in this report shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Act of 1934, whether made before or after the date hereof and regardless of any general incorporation language in such filing, except as expressly set forth by specific reference in such filing.

Caution Concerning Forward-Looking Statements

This Form 8-K contains information that includes or is based on forward-looking statements within the meaning of the federal securities laws that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such statements include, but are not limited to, those regarding our financial performance and the impact of the COVID-19 pandemic on our operations and financial results and are subject to, among other risks, the COVID-19 pandemic and any related policies and actions by governments or other third parties. Additional information concerning these and other factors is contained in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q that we have filed or will file hereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statement to reflect any change in our expectations or in events, conditions or circumstances on which those expectations may be based, or that affect the likelihood that actual results will differ from those contained in the forward-looking statements.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit   Description
99.1        Press release dated October 29, 2020


                                 Exhibit Index

Exhibit   Description
 99.1       Press release dated October 29, 2020

  104     Cover Page Interactive Data File (embedded with the Inline XBRL document)


© Edgar Online, source Glimpses

All news about ABIOMED, INC.
01/14ABIOMED : Third Quarter Fiscal 2021 Earnings and Conference Call Notification
01/07ABIOMED : Continues to Strengthen its Intellectual Property, Now Holds More Than..
01/06Artificial heartmaker Carmat to start sales after EU approval
01/01ABIOMED : Significant Insider Selling in Shares of Abiomed (ABMD) Continues
2020INSIDER TRENDS : Abiomed Insider Extends 90-Day Selling Trend
2020Stocks End Lower After Push for Higher Stimulus Payments Stalls in Senate
2020ABIOMED : to Present at the 39th Annual J.P. Morgan Healthcare Conference
2020ABIOMED : ABMD) sees Significant Insider Selling Continuing
2020INSIDER TRENDS : Selling By Insiders Endures at Abiomed
2020ABIOMED : First Patients, Including a COVID-19 Patient, Treated with Abiomed's I..
More news